Quick Answer
INTEGRA LIFESCIENCES HOLDINGS CORP reported R&D Expense of $78.04 million for fiscal year 2018.
INTEGRA LIFESCIENCES HOLDINGS CORP R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2018 | $78.04M | +23.0% |
| 2017 | $63.45M | +9.1% |
| 2016 | $58.16M | +14.3% |
| 2015 | $50.90M | +16.8% |
| 2014 | $43.56M | +2.2% |
| 2013 | $42.62M | -16.4% |
| 2012 | $51.01M | -0.9% |
| 2011 | $51.45M | +6.9% |
| 2010 | $48.11M | +8.7% |
| 2009 | $44.28M | -26.8% |
| 2008 | $60.49M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| June 30, 2020 | $14.93M | -15.4% | -28.3% |
| March 31, 2020 | $20.82M | +13.6% | +9.5% |
| September 30, 2019 | $19.00M | -6.4% | +7.8% |
| June 30, 2019 | $17.63M | -7.7% | -3.8% |
| March 31, 2019 | $18.32M | -0.0% | -9.8% |
| September 30, 2018 | $20.31M | +35.1% | +6.3% |
| June 30, 2018 | $19.11M | +21.3% | +4.3% |
| March 31, 2018 | $18.32M | +18.3% | +21.9% |
- INTEGRA LIFESCIENCES HOLDINGS CORP showed an increase of +23.0% in R&D Expense compared to the prior fiscal year.
- Over the 2008–2018 period, INTEGRA LIFESCIENCES HOLDINGS CORP’s r&d expense has grown by 29.0% (from $60.49 million to $78.04 million).
- The most recent figure is from INTEGRA LIFESCIENCES HOLDINGS CORP’s fiscal year 2018 report (Form 10-K), filed with the SEC on February 26, 2019.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: